Literature DB >> 20683931

A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.

Silvia Ferri1, Maria Serena Longhi, Chiara De Molo, Claudine Lalanne, Paolo Muratori, Alessandro Granito, Munther J Hussain, Yun Ma, Marco Lenzi, Giorgina Mieli-Vergani, Francesco B Bianchi, Diego Vergani, Luigi Muratori.   

Abstract

UNLABELLED: Immunotolerance is maintained by regulatory T cells (Tregs), including CD4(+)CD25(hi), CD8(+)CD28(-), gammadelta, and CD3(+)CD56(+) [natural killer T (NKT)] cells. CD4(+)CD25(hi) cells are impaired in children with autoimmune hepatitis (AIH). Little is known about Tregs in adults with AIH. The aim of this study was to investigate the frequency and function of Treg subsets in adult patients with AIH during periods of active disease and remission. Forty-seven AIH patients (16 with active disease and 31 in remission) and 28 healthy controls were studied. Flow cytometry was used to evaluate surface markers and function-related intracellular molecules in gammadelta, CD8(+)CD28(-), NKT, and CD4(+)CD25(hi) cells. CD4(+)CD25(hi) T cell function was determined by the ability to suppress proliferation and interferon gamma (IFN-gamma) production by CD4(+)CD25(-) target cells. Liver forkhead box P3-positive (FOXP3(+)) cells were sought by immunohistochemistry. In AIH patients, particularly during active disease, CD4(+)CD25(hi) T cells were fewer, expressed lower levels of FOXP3, and were less effective at inhibiting target cell proliferation versus healthy controls. Moreover, although the numbers of CD8(+)CD28(-) T cells were similar in AIH patients and healthy controls, NKT cells were numerically reduced, especially during active disease, and produced lower quantities of the immunoregulatory cytokine interleukin-4 versus controls. In contrast, gammadelta T cells in AIH patients were more numerous versus healthy controls and had an inverted Vdelta1/Vdelta2 ratio and higher IFN-gamma and granzyme B production; the latter was correlated to biochemical indices of liver damage. There were few FOXP3(+) cells within the portal tract inflammatory infiltrate.
CONCLUSION: Our data show that the defect in immunoregulation in adult AIH is complex, and gammadelta T cells are likely to be effectors of liver damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683931     DOI: 10.1002/hep.23792

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  65 in total

Review 1.  Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation.

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Hepatology       Date:  2017-05-27       Impact factor: 17.425

Review 2.  Juvenile autoimmune hepatitis: Spectrum of the disease.

Authors:  Giuseppe Maggiore; Silvia Nastasio; Marco Sciveres
Journal:  World J Hepatol       Date:  2014-07-27

Review 3.  Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications.

Authors:  Ilan Bank; Victoria Marcu-Malina
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

4.  A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.

Authors:  Muhammed Yuksel; Yipeng Wang; Ningwen Tai; Jian Peng; Junhua Guo; Kathie Beland; Pascal Lapierre; Chella David; Fernando Alvarez; Isabelle Colle; Huiping Yan; Giorgina Mieli-Vergani; Diego Vergani; Yun Ma; Li Wen
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

Review 5.  γδ-T cells: an unpolished sword in human anti-infection immunity.

Authors:  Jian Zheng; Yinping Liu; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2012-10-15       Impact factor: 11.530

Review 6.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

7.  The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.

Authors:  M Yuksel; X Xiao; N Tai; Manakkat Vijay; E Gülden; K Beland; P Lapierre; F Alvarez; Z Hu; I Colle; Y Ma; L Wen
Journal:  Clin Exp Immunol       Date:  2016-08-23       Impact factor: 4.330

Review 8.  Cutting edge issues in autoimmune hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 9.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

10.  Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy.

Authors:  Kelly W Burak; Mark G Swain; Tania Santodomingo-Garzon; Tania Santodomino-Garzon; Samuel S Lee; Stefan J Urbanski; Alexander I Aspinall; Carla S Coffin; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2013       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.